Nicotine patch safe during pregnancy
This article was originally published in The Tan Sheet
Executive Summary
Long-term nicotine replacement therapy advocated for pregnant women otherwise unable to stop smoking by Paul Ogburn, MD, State University of New York at Stony Brook, et al. Researchers found 22 mg/24 hrs of transdermal nicotine therapy administered for eight weeks did not affect gestational age, birth weight or "fetal well-being" in cohort of 21 pregnant smokers. Study was presented at Society for Maternal-Fetal Medicine's annual meeting in New Orleans Jan. 17 and published in December American Journal of Obstetrics & Gynecology. A California judge ruled last March against requiring that nonprescription NRT products carry labeling stating they "can harm your baby" (1"The Tan Sheet" March 26, 2001, p. 21)...
You may also be interested in...
Smoking Cessation Patch, Gum Prop 65 Warning Federally Preempted - Court
Requiring a special California Proposition 65 pregnancy warning on OTC nicotine-containing smoking cessation patches and gums would conflict with FDA requirements, a San Francisco state court judge has ruled.
CDER, CBER Not Seeing Hiring Slowdown Despite US FDA Warnings
FDA officials have said hiring could be slowed if an inflationary pay increase is not included in the agency budget, but CDER and CBER continue to add staff at a steady pace.
Medicare Reimbursement For Part B Drugs Is 48% Above 340B Prices To Hospitals, MedPAC Finds
New study updates past commission analyses and highlights the significant margin between Medicare payments for drugs and the prices paid by 340B-eligible providers.